Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.77
Delayed Data
As of Aug 16
 +0.05 / +1.06%
Today’s Change
1.29
Today|||52-Week Range
5.03
+200.00%
Year-to-Date

Today’s Trading

Previous close4.72
Today’s open4.75
Day’s range4.71 - 4.85
Volume1,028,501
Average volume (3 months)1,495,026
Market cap$665.6M
Data as of 4:00pm ET, 08/16/2019

Growth & Valuation

Earnings growth (last year)+18.11%
Earnings growth (this year)-19.61%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
ZEALZealand Pharma A/S-0.60-2.75%
TGTXTG Therapeutics Inc+0.29+4.43%
TXMDTherapeuticsMD Inc-0.11-3.70%
SVASinovac Biotech Ltd0.000.00%
Data as of 4:00pm ET, 08/16/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$70.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Joseph Truitt
Chief Operating Officer &
Executive Vice President
Paul Firuta
Corporate headquarters
Blue Bell, Pennsylvania

Forecasts